Short-Term Pretransplant Renal Replacement Therapy and Renal Nonrecovery after Liver Transplantation Alone

Clinical Journal of the American Society of Nephrology

Volumn 8, Issue 7, 2013, Pages 1135-1142

  Sharma, Pratima ^a   Goodrich, Nathan P ^b   Zhang, Min ^c   Guidinger, Mary K ^c   Schaubel, Douglas E ^c   Merion, Robert M ^b,c  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b ARBOR RESEARCH COLLABORATIVE FOR HEALTH   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BILIRUBIN BLOOD LEVEL; CHRONIC KIDNEY DISEASE; CREATININE BLOOD LEVEL; DIABETES MELLITUS; FEMALE; HUMAN; INCIDENCE; KIDNEY FUNCTION; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PROPORTIONAL HAZARDS MODEL; PROTHROMBIN TIME; RENAL REPLACEMENT THERAPY; RISK FACTOR;

ACUTE KIDNEY INJURY; CENTERS FOR MEDICARE AND MEDICAID SERVICES (U.S.); DISEASE PROGRESSION; FEMALE; HEPATORENAL SYNDROME; HUMANS; KIDNEY; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PREOPERATIVE CARE; PROPORTIONAL HAZARDS MODELS; RECOVERY OF FUNCTION; REGISTRIES; RENAL REPLACEMENT THERAPY; RETROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS; TISSUE AND ORGAN PROCUREMENT; TREATMENT OUTCOME; UNITED STATES; WAITING LISTS;

EID: 84879822438     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.09600912     Document Type: Article

References (29)

1. Gonwa TA, McBride MA, Anderson K, Mai ML, Wadei H, Ahsan N: Continued influence of preoperative renal function on outcome of orthotopic liver transplant (OLTX) in the US: Where will MELD lead us? Am J Transplant 6: 2651-2659, 2006
2. Eason JD, Gonwa TA, Davis CL, Sung RS, Gerber D, Bloom RD: Proceedings of Concensus Conference on Simultaneous Liver Kidney Transplantation (SLK). Am J Transplant 8: 2243-2251, 2000
3. Brensing KA, Textor J, Perz J, Schiedermaier P, Raab P, Strunk H, Klehr HU, Kramer HJ, Spengler U, Schild H, Sauerbruch T: Long term outcome after transjugular intrahepatic portosystemic stentshunt in non-transplant cirrhotics with hepatorenal syndrome: A phase II study. Gut 47: 288-295, 2000
4. Martín-Llahí M, Pépin MN, Guevara M, Díaz F, Torre A, Monescillo A, Soriano G, Terra C, Fábrega E, Arroyo V, Rodés J, Ginès P; TAHRS Investigators: Terlipressin and albumin vs albumin in patients with cirrhosis and hepatorenal syndrome: A randomized study. Gastroenterology 134: 1352-1359, 2008
5. Sanyal AJ, Boyer T, Garcia-Tsao G, Regenstein F, Rossaro L, Appenrodt B, Blei A, Gülberg V, Sigal S, Teuber P; Terlipressin Study Group: A randomized, prospective, double-blind, placebocontrolled trial of terlipressin for type 1 hepatorenal syndrome. Gastroenterology 134: 1360-1368, 2008
6. Angeli P, Volpin R, Gerunda G, Craighero R, Roner P, Merenda R, Amodio P, Sticca A, Caregaro L, Maffei-Faccioli A, Gatta A: Reversal of type 1 hepatorenal syndrome with the administration of midodrine and octreotide. Hepatology 29: 1690-1697, 1999
7. Runyon BA; AASLD Practice Guidelines Committee: Management of adult patients with ascites due to cirrhosis: An update. Hepatology 49: 2087-2107, 2009
8. Moreau R, Lebrec D: Acute renal failure in patients with cirrhosis: Perspectives in the age of MELD. Hepatology 37: 233-243, 2003
9. Northup PG, Argo CK, Bakhru MR, Schmitt TM, Berg CL, Rosner MH: Pretransplant predictors of recovery of renal function after liver transplantation. Liver Transpl 16: 440-446, 2010
10. Levine GN, McCullough KP, Rodgers AM, Dickinson DM, Ashby VB, Schaubel DE: Analytical methods and database design: Implications for transplant researchers, 2005. Am J Transplant 6: 1228-1242, 2006
11. United Network for Organ Sharing: 3.6 Allocation of Livers, 2005. Available at: http://optn.transplant.hrsa.gov/PoliciesandBylaws2/policies/pdfs/policy_8.pdf. Accessed on November 30, 2012
12. Kalbfleisch JD, Prentice RL: The Statistical Analysis of Failure Time Data, 2nd Ed., New York, Wiley, 2002
13. Bahirwani R, Campbell MS, Siropaides T, Markmann J, Olthoff K, Shaked A, Bloom RD, Reddy KR: Transplantation: Impact of pretransplant renal insufficiency. Liver Transpl 14: 665-671, 2008
14. Gonwa TA, Klintmalm GB, Levy M, Jennings LS, Goldstein RM, Husberg BS: Impact of pretransplant renal function on survival after liver transplantation. Transplantation 59: 361-365, 1995
15. Nair S, Verma S, Thuluvath PJ: Pretransplant renal function predicts survival in patients undergoing orthotopic liver transplantation. Hepatology 35: 1179-1185, 2002
16. Ojo AO, Held PJ, Port FK, Wolfe RA, Leichtman AB, Young EW, Arndorfer J, Christensen L, Merion RM: Chronic renal failure after transplantation of a nonrenal organ. N Engl J Med 349: 931-940, 2003
17. Campbell MS, Kotlyar DS, Brensinger CM, Lewis JD, Shetty K, Bloom RD, Markmann JF, Olthoff KM, Shaked A, Reddy KR: Renal function after orthotopic liver transplantation is predicted by duration of pretransplantation creatinine elevation. Liver Transpl 11: 1048-1055, 2005
18. Sharma P, Welch K, Eikstadt R, Marrero JA, Fontana RJ, Lok AS: Renal outcomes after liver transplantation in the model for endstage liver disease era. Liver Transpl 15: 1142-1148, 2009
19. Nadim MK, Davis CL, Sung R, Kellum JA, Genyk YS: Simultaneous liver-kidney transplantation: A survey of US transplant centers. Am J Transplant 12: 3119-3127, 2012
20. Nadim MK, Sung RS, Davis CL, Andreoni KA, Biggins SW, Danovitch GM, Feng S, Friedewald JJ, Hong JC, Kellum JA, Kim WR, Lake JR, Melton LB, Pomfret EA, Saab S, Genyk YS: Simultaneous liver-kidney transplantation summit: Current state and future directions. Am J Transplant 12: 2901-2908, 2012
21. Davis CL, Feng S, Sung R, Wong F, Goodrich NP, Melton LB, Reddy KR, Guidinger MK, Wilkinson A, Lake J: Simultaneous liver-kidney transplantation: Evaluation to decisionmaking. AmJ Transplant 7: 1702-1709, 2007
22. Davis CL: Impact of implementation of the MELD scoring system on the prevalence and incidence of chronic renal disease following liver transplantation. Liver Transpl 12: 707-709, 2006
23. Ruiz R, Kunitake H, Wilkinson AH, Danovitch GM, Farmer DG, Ghobrial RM, Yersiz H, Hiatt JR, Busuttil RW: Long-term analysis of combined liver and kidney transplantation at a single center. Arch Surg 141: 735-741, discussion 741-742, 2006
24. United Network for Organ Sharing: 3.6 Organ Distribution: Allocation of Livers, 2002. Available at: http://optn.transplant.hrsa.gov/PoliciesandBylaws2/policies/pdfs/policy_8.pdf. Accessed on November 30, 2012
25. Levitsky J, Baker T, Ahya SN, Levin ML, Friedewald J, Gallon L, Ho B, Skaro A, Krupp J, Wang E, Spies SM, Salomon DR, Abecassis MM: Outcomes and native renal recovery following simultaneous liver-kidney transplantation. Am J Transplant 12: 2949-2957, 2012
26. Onaca NN, Levy MF, Netto GJ, Thomas MJ, Sanchez EQ, Chinnakotla S, Fasola CG, Weinstein JS, Murray N, Goldstein RM, Klintmalm GB: Pretransplant MELD score as a predictor of outcome after liver transplantation for chronic hepatitis C. Am J Transplant 3: 626-630, 2003
27. Saab S, Wang V, Ibrahim AB, Durazo F, Han S, Farmer DG, Yersiz H, Morrisey M, Goldstein LI, Ghobrial RM, Busuttil RW: MELD score predicts 1-year patient survival post-orthotopic liver transplantation. Liver Transpl 9: 473-476, 2003
28. Narayanan Menon KV, Nyberg SL, Harmsen WS, DeSouza NF, Rosen CB, Krom RA, Wiesner RH: MELD and other factors associated with survival after liver transplantation. Am J Transplant 4: 819-825, 2004
29. Feng S, Goodrich NP, Bragg-Gresham JL, Dykstra DM, Punch JD, DebRoy MA, Greenstein SM, Merion RM: Characteristics associated with liver graft failure: The concept of a donor risk index. Am J Transplant 6: 783-790, 2006